
Polymarket secures CFTC’s no-action letter, paving the way for its return to the U.S. market after its 2022 settlement, with a series of strategic acquisitions and investments bolstering its position.
Polymarket has secured approval from the U.S. Commodity Futures Trading Commission (CFTC) to reenter the U.S. market through its acquisition of QCX, a U.S.-registered derivatives exchange. The decision follows a series of strategic moves including a $112 million acquisition, major institutional investments, and high-profile board appointments, and sets the stage for Polymarket to resume offering compliant prediction contracts to U.S. users after a 2022 settlement. Despite regulatory challenges, including allegations of market manipulation and restrictions in several international markets, Polymarket continues to expand, processing over $6 billion in bets in the first half of 2025 alone.